FR2290888B1 - - Google Patents

Info

Publication number
FR2290888B1
FR2290888B1 FR7535137A FR7535137A FR2290888B1 FR 2290888 B1 FR2290888 B1 FR 2290888B1 FR 7535137 A FR7535137 A FR 7535137A FR 7535137 A FR7535137 A FR 7535137A FR 2290888 B1 FR2290888 B1 FR 2290888B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7535137A
Other versions
FR2290888A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FR2290888A1 publication Critical patent/FR2290888A1/fr
Application granted granted Critical
Publication of FR2290888B1 publication Critical patent/FR2290888B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K26/00—Working by laser beam, e.g. welding, cutting or boring
    • B23K26/08—Devices involving relative movement between laser beam and workpiece
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K26/00—Working by laser beam, e.g. welding, cutting or boring
    • B23K26/08—Devices involving relative movement between laser beam and workpiece
    • B23K26/083—Devices involving movement of the workpiece in at least one axial direction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K26/00—Working by laser beam, e.g. welding, cutting or boring
    • B23K26/36—Removing material
    • B23K26/38—Removing material by boring or cutting
    • B23K26/382—Removing material by boring or cutting by boring
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K2103/00—Materials to be soldered, welded or cut
    • B23K2103/30—Organic material
    • B23K2103/42—Plastics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K2103/00—Materials to be soldered, welded or cut
    • B23K2103/50—Inorganic material, e.g. metals, not provided for in B23K2103/02 – B23K2103/26

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Health & Medical Sciences (AREA)
  • Plasma & Fusion (AREA)
  • Mechanical Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Treatment Of Fiber Materials (AREA)
  • Laser Beam Processing (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
FR7535137A 1974-11-18 1975-11-18 Procede de faconnage de passages de sortie dans des pilules en utilisant un laser Granted FR2290888A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52458574A 1974-11-18 1974-11-18

Publications (2)

Publication Number Publication Date
FR2290888A1 FR2290888A1 (fr) 1976-06-11
FR2290888B1 true FR2290888B1 (fr) 1979-01-05

Family

ID=24089826

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7535137A Granted FR2290888A1 (fr) 1974-11-18 1975-11-18 Procede de faconnage de passages de sortie dans des pilules en utilisant un laser

Country Status (10)

Country Link
US (1) US4088864A (fr)
JP (1) JPS609814B2 (fr)
AU (1) AU498851B2 (fr)
CA (1) CA1033013A (fr)
CH (1) CH604696A5 (fr)
DE (1) DE2551241C2 (fr)
FR (1) FR2290888A1 (fr)
GB (1) GB1478759A (fr)
IT (1) IT1050948B (fr)
SE (1) SE420804B (fr)

Families Citing this family (398)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS538034A (en) * 1976-06-30 1978-01-25 Toshiba Corp Electronic computer
US4297559A (en) * 1979-05-10 1981-10-27 Olin Corporation Apparatus for controlled perforation of moving webs with fixed focus laser beam
US4380855A (en) * 1980-01-18 1983-04-26 University Of Rochester Method for filling hollow shells with gas for use as laser fusion targets
GB2073639A (en) * 1980-02-20 1981-10-21 Duracell Int Apparatus and method for spot heat treating workpieces
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4344929A (en) * 1980-04-25 1982-08-17 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4439195A (en) * 1980-10-14 1984-03-27 Alza Corporation Theophylline therapy
US4484921A (en) * 1982-02-01 1984-11-27 Alza Corporation Theophylline therapy utilizing osmotic delivery
US4539060A (en) * 1983-02-18 1985-09-03 Warner-Lambert Company Apparatus and method of sealing capsules
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
US4595583A (en) * 1984-03-19 1986-06-17 Alza Corporation Delivery system controlled administration of beneficial agent to ruminants
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US5000957A (en) * 1984-03-19 1991-03-19 Alza Corporation Dispenser comprising hydrophilic osmopolymer
US4927633A (en) * 1984-03-19 1990-05-22 Alza Corporation Dispenser for delivering drug to livestock
US4612186A (en) * 1984-03-19 1986-09-16 Alza Corporation Method for establishing blood levels of biocide in animals
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4624945A (en) * 1984-03-19 1986-11-25 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4692336A (en) * 1984-03-19 1987-09-08 Alza Corporation Self controlled release device for administering beneficial agent to recipient
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
US4627971A (en) * 1985-04-22 1986-12-09 Alza Corporation Osmotic device with self-sealing passageway
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4717568A (en) * 1985-08-09 1988-01-05 Alza Corporation Laminar arrangement for increasing delivery of beneficial agent from dispenser
US4717718A (en) * 1985-08-09 1988-01-05 Alza Corporation Device for the controlled delivery of a beneficial agent
US5098425A (en) * 1985-08-16 1992-03-24 Alza Corporation Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
US4883667A (en) * 1985-08-16 1989-11-28 Alza Corporation Process for forming dispensing device
US4675174A (en) * 1985-08-16 1987-06-23 Alza Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
US4871544A (en) * 1985-08-16 1989-10-03 Alza Corporation Ruminant dispensing device
US4966767A (en) * 1985-08-16 1990-10-30 Alza Corporation Ruminant dispensing device comprising agent displacement member
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4955881A (en) * 1985-08-16 1990-09-11 Alza Corporation Ruminant dispensing device
US4865598A (en) * 1985-08-16 1989-09-12 Alza Corporation Dispensing system for administering beneficial agent
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US4950486A (en) * 1987-10-02 1990-08-21 Alza Corporation Dosage form for treating cardiovascular diseases
US4946687A (en) * 1987-10-02 1990-08-07 Alza Corporation Dosage form for treating cardiovascular diseases
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US4996060A (en) * 1988-03-25 1991-02-26 Alza Corporation Device comprising liner for protecting fluid sensitive medicament
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4959218A (en) * 1988-03-25 1990-09-25 Alza Corporation Method for delivering somatotropin to an animal
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5006346A (en) * 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US5160743A (en) * 1988-04-28 1992-11-03 Alza Corporation Annealed composition for pharmaceutically acceptable drug
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US4873414A (en) * 1988-06-13 1989-10-10 Rolls Royce Inc. Laser drilling of components
US4896944A (en) * 1988-07-25 1990-01-30 Irwin Timothy L Method and apparatus for trepanning workpieces
US5096716A (en) * 1988-09-01 1992-03-17 Alza Corporation Dosage form for administering calcium antagonist nicardipine
US5030456A (en) * 1988-11-07 1991-07-09 Alza Corporation Dosage form for treating cardiovascular diseases
US5110596A (en) * 1988-12-13 1992-05-05 Alza Corporation Delivery system comprising means for delivering agent to livestock
US5135523A (en) * 1988-12-13 1992-08-04 Alza Corporation Delivery system for administering agent to ruminants and swine
US5728088A (en) * 1988-12-13 1998-03-17 Alza Corporation Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
US5059423A (en) * 1988-12-13 1991-10-22 Alza Corporation Delivery system comprising biocompatible beneficial agent formulation
US5174999A (en) * 1988-12-13 1992-12-29 Alza Corporation Delivery system comprising fluid ingress and drug egress
US5037420A (en) * 1988-12-13 1991-08-06 Alza Corporation Delivery system comprising two sections for delivering somatotropin
US5034229A (en) 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US5057318A (en) * 1988-12-13 1991-10-15 Alza Corporation Delivery system for beneficial agent over a broad range of rates
US5186942A (en) * 1989-01-30 1993-02-16 Alza Corporation Nicardipine therapy
US5019396A (en) * 1989-05-12 1991-05-28 Alza Corporation Delivery dispenser for treating cardiac arrhythmias
US5063280A (en) * 1989-07-24 1991-11-05 Canon Kabushiki Kaisha Method and apparatus for forming holes into printed circuit board
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US20020197309A1 (en) * 1989-09-05 2002-12-26 Kuczynski Anthony L. Method for lowering blood glucose
US5091190A (en) * 1989-09-05 1992-02-25 Alza Corporation Delivery system for administration blood-glucose lowering drug
US6361795B1 (en) 1989-09-05 2002-03-26 Alza Corporation Method for lowering blood glucose
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5238687A (en) * 1990-07-11 1993-08-24 Alza Corporation Delivery device with a protective sleeve
US5234694A (en) * 1990-07-11 1993-08-10 Alza Corporation Method for increasing feed efficiency in animals
US5234693A (en) * 1990-07-11 1993-08-10 Alza Corporation Delivery device with a protective sleeve
US5234692A (en) * 1990-07-11 1993-08-10 Alza Corporation Delivery device with a protective sleeve
US5180591A (en) * 1990-07-11 1993-01-19 Alza Corporation Delivery device with a protective sleeve
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
JPH0460918U (fr) * 1990-09-29 1992-05-26
PL169904B1 (pl) * 1991-01-17 1996-09-30 United Distillers Plc Sposób i urzadzenie do znakowania poruszajacych sie wyrobów PL PL PL
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5861166A (en) * 1991-03-12 1999-01-19 Alza Corporation Delivery device providing beneficial agent stability
JPH04121915U (ja) * 1991-04-09 1992-10-30 株式会社椿本チエイン オーバーヘツドコンベヤの搬送物保護構造
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5137727A (en) * 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5294770A (en) * 1992-01-14 1994-03-15 Alza Corporation Laser tablet treatment system with dual access to tablet
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
US5688518A (en) * 1992-02-27 1997-11-18 Alza Corporation Antidepressive therapy
US5185158A (en) * 1992-02-27 1993-02-09 Alza Corporation Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
US5858407A (en) * 1992-02-27 1999-01-12 Alza Corporation Method for administering tandospirone
US5246711A (en) * 1992-02-27 1993-09-21 Alza Corporation Dosage form for treating dysthymia
US5246710A (en) * 1992-02-27 1993-09-21 Alza Corporation Dosage form for treating cyclothymia
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5532003A (en) * 1994-01-18 1996-07-02 Alza Corporation Pentoxifylline therapy
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5718700A (en) * 1994-09-20 1998-02-17 Alza Corporation Exit means in dosage form
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US5658474A (en) * 1994-12-16 1997-08-19 Alza Corporation Method and apparatus for forming dispenser delivery ports
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5674895A (en) * 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US6124355A (en) * 1995-05-22 2000-09-26 Guittard; George V. Oxybutynin therapy
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
US5690952A (en) * 1995-06-07 1997-11-25 Judy A. Magruder et al. Implantable system for delivery of fluid-sensitive agents to animals
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
DE69734920T2 (de) * 1996-02-29 2006-09-07 Merck & Co., Inc. Laserbohrverfahren zur herstellung einer vielzahl von löchern in chemischen dosierungsformen
DE69730027T2 (de) * 1996-05-24 2004-11-25 Alza Corp., Mountain View Abgabevorrichtung zur Abgabe eines Farbstoffs an eine Nähstoffformulie- rung
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US6190351B1 (en) 1997-02-28 2001-02-20 Alza Corporation Nutritional support system
US6110499A (en) * 1997-07-24 2000-08-29 Alza Corporation Phenytoin therapy
US6514530B2 (en) 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape
US7060734B1 (en) 1997-09-09 2006-06-13 Alza Corporation Pharmaceutical coating composition and method of use
ATE282407T1 (de) * 1997-09-09 2004-12-15 Alza Corp Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung
US20040062799A1 (en) * 1997-09-29 2004-04-01 Ayer Atul D. Therapeutic composition and delivery system for administering drug
AU1534699A (en) 1997-12-05 1999-06-28 Alza Corporation Osmotic dosage form comprising first and second coats
US8679534B2 (en) * 1997-12-12 2014-03-25 Andrx Labs, Llc HMG-CoA reductase inhibitor extended release formulation
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
JP2001526229A (ja) * 1997-12-22 2001-12-18 ユーロ−セルティーク，エス．エイ． オピオイド投薬剤形の乱用を防止する方法
ES2412409T3 (es) 1997-12-22 2013-07-11 Euro-Celtique S.A. Forma farmacéutica para dosificación oral que comprende una combinación de un agonista opiáceo y un antagonista opiáceo
US6245357B1 (en) 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
AR018321A1 (es) * 1998-03-26 2001-11-14 Alza Corp Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
US20010038855A1 (en) * 1998-06-05 2001-11-08 Desjardin Michael A. Dosage form for administering prescribed dose
TW407058B (en) 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
JP2002528486A (ja) 1998-11-02 2002-09-03 アルザ・コーポレーション 有効物質の送達制御
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6452133B1 (en) * 1999-07-26 2002-09-17 Alza Corporation Apparatus and methods for alternating laser treatment of pharmaceutical dispensers
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
ES2374717T3 (es) 1999-10-29 2012-02-21 Euro-Celtique S.A. Formulaciones de hidrocodona de liberación controlada.
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
WO2001038036A1 (fr) * 1999-11-29 2001-05-31 Siemens Production And Logistics Systems Ag Procede et dispositif de traitement de substrats au moyen de rayons lasers
AU780045B2 (en) * 1999-12-16 2005-02-24 Alza Corporation Dosage forms having a barrier layer to laser ablation
EP1935421A1 (fr) 2000-02-08 2008-06-25 Euro-Celtique S.A. Compositions à libération contrôlée contenant un agoniste et antagoniste opioïde
GEP20053614B (en) 2000-02-08 2005-09-26 Euro Celtique Sa Compositions for Oral Administration Containing Opioid Agonist
GB0003260D0 (en) * 2000-02-11 2000-04-05 Weston Medical Ltd A method of forming a drug capsule for a needlefree injector
US6791592B2 (en) * 2000-04-18 2004-09-14 Laserink Printing a code on a product
EP1151673A3 (fr) * 2000-05-03 2002-01-02 Societe Des Produits Nestle S.A. Confiserié avec remplissage
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
WO2002036099A1 (fr) 2000-10-30 2002-05-10 Euro-Celtique S.A. Preparations d'hydrocodone a liberation lente
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
KR20030061392A (ko) 2000-11-03 2003-07-18 안드렉스 코포레이션 방출 조절성 메트포민 조성물
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
WO2002043785A2 (fr) 2000-11-29 2002-06-06 Oculex Pharmaceuticals, Inc. Procedes permettant de reduire ou prevenir le rejet de greffe dans l'oeil et implants intraoculaires utilises a cet effet
JP2002234417A (ja) * 2000-12-04 2002-08-20 Takata Corp シートベルト巻き取り装置
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
CA2446550C (fr) 2001-05-11 2012-03-06 Endo Pharmaceuticals, Inc. Forme posologique d'opioides a liberation prolongee empechant la consommation abusive
US7569794B2 (en) * 2001-05-23 2009-08-04 Osmotica Corp. Laser drilling system and method
US6809288B2 (en) * 2001-05-23 2004-10-26 Osmotica Corp. Laser drilling system and method
US7232924B2 (en) * 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
ES2380287T3 (es) * 2001-06-11 2012-05-10 Xenoport, Inc. Profármacos de análogos de GABA, composiciones y sus usos
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1412324A4 (fr) * 2001-06-11 2004-09-29 Xenoport Inc Conjugues d'amino acides permettant d'obtenir des concentrations systemiques soutenues d'analogues du gaba
WO2003013433A2 (fr) * 2001-08-06 2003-02-20 Euro-Celtique S.A. Formulations d'antagoniste sequestre
AU2002323032B2 (en) 2001-08-06 2005-02-24 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US6828049B2 (en) 2001-10-29 2004-12-07 Hewlett-Packard Development Company, L.P. Replaceable fuel cell apparatus having information storage device
US6756564B2 (en) * 2001-12-31 2004-06-29 Andrx Pharmaceuticals Llc System and method for removing particulate created from a drilled or cut surface
EP2522319A3 (fr) * 2002-03-11 2013-09-25 Novartis AG Système de distribution de médicament implantable
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
DE60322371D1 (de) * 2002-03-29 2008-09-04 Alza Corp Volumensparende arzneiform zur kontrollierten freisetzung
CA2708900C (fr) * 2002-04-05 2019-06-04 Purdue Pharma Preparation pharmaceutique contenant oxycodone et naloxone
US20050106249A1 (en) * 2002-04-29 2005-05-19 Stephen Hwang Once-a-day, oral, controlled-release, oxycodone dosage forms
US20040052848A1 (en) * 2002-05-23 2004-03-18 Xiu-Xiu Cheng Biguanide formulations
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
JP2005533657A (ja) * 2002-07-24 2005-11-10 ファイザー・プロダクツ・インク 薬剤用のレーザー穴あけ装置
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
JP2005536568A (ja) * 2002-07-29 2005-12-02 アルザ・コーポレーシヨン トピラメートの調節分配用の調剤および投薬形態
CN1674873A (zh) 2002-08-15 2005-09-28 欧罗赛铁克股份有限公司 药物组合物
EP1551356A2 (fr) 2002-09-03 2005-07-13 Biovail Laboratories Incorporated Formulations pharmaceutiques de pravastatin et leurs modes d'utilisation
DK1551372T3 (en) 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
AU2003293423A1 (en) 2002-12-06 2004-06-30 Xenoport, Inc. Carbidopa prodrugs and uses thereof
WO2004053192A1 (fr) * 2002-12-11 2004-06-24 Xenoport, Inc. Formes posologiques administrees oralement de promedicaments analogues de gaba fondu a toxicite reduite
WO2004054542A2 (fr) 2002-12-13 2004-07-01 Durect Corporation Systeme d'administration de medicaments par voie orale
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
EP1572190B1 (fr) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comportant de l'acide fenofibrique, un sel ou un derive physiologiquement acceptable de cet acide
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
EP2339328A3 (fr) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques cocrystallisees de celecoxib
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
KR20050095835A (ko) * 2003-01-14 2005-10-04 알자 코포레이션 조정된 점성층을 갖는 방법 및 제형
CA2515641A1 (fr) * 2003-02-11 2004-08-26 Alza Corporation Methodes et formes dosifiees presentant une geometrie de couche modifiee
EP1452263B1 (fr) * 2003-02-27 2007-01-24 Osmotica Corp. Système et méthode de perçage par laser
EP1608357A4 (fr) * 2003-03-31 2008-03-26 Xenoport Inc Traitement ou prevention des bouffees de chaleur par utilisation de promedicaments a base d'analogues des gaba
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
US20060177507A1 (en) * 2003-05-22 2006-08-10 Joaquina Faour Controlled release device containing lercanidipine
US20050058707A1 (en) * 2003-08-06 2005-03-17 Iran Reyes Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
KR101140559B1 (ko) * 2003-08-20 2012-07-05 제노포트 인코포레이티드 아실옥시알킬 카르바메이트 프로드러그, 합성 및 사용 방법
EP2354120A1 (fr) 2003-08-20 2011-08-10 XenoPort, Inc. Synthèse de promédicaments a base de carbamate d'acyloxyalkyle et leurs intermédiaires
US20050136108A1 (en) * 2003-08-22 2005-06-23 Yam Noymi V. Stepwise delivery of topiramate over prolonged period of time
EP1701697A2 (fr) * 2003-09-02 2006-09-20 ALZA Corporation Compositions medicamenteuses et formes pharmaceutiques de topiramate
EP1670451A4 (fr) * 2003-09-11 2009-10-21 Xenoport Inc Traitement et/ou prevention de l'incontinence urinaire et promedicaments des analogues gaba
CN1871021B (zh) * 2003-09-17 2010-07-28 什诺波特有限公司 用gaba类似物的前药治疗或预防多动腿综合征
EP2298303A1 (fr) 2003-09-25 2011-03-23 Euro-Celtique S.A. Combinaisons pharmaceutiques d'hydrocodone et de naltrexone
ATE544447T1 (de) * 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
DE602004032149D1 (de) * 2003-09-26 2011-05-19 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
CA2540056C (fr) * 2003-09-26 2015-03-24 Alza Corporation Preparations a liberation regulee a base d'analgesiques opioides et non opioides
US20050088510A1 (en) * 2003-10-24 2005-04-28 Shlomo Assa Low angle optics and reversed optics
US8987322B2 (en) 2003-11-04 2015-03-24 Circ Pharma Research And Development Limited Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
WO2005060968A1 (fr) 2003-12-11 2005-07-07 Sepracor Inc. Combinaison d'un sedatif et d'un modulateur des neurotransmetteurs, et methodes permettant d'ameliorer la qualite du sommeil et de traiter la depression
US7046267B2 (en) * 2003-12-19 2006-05-16 Markem Corporation Striping and clipping correction
CA2550866A1 (fr) * 2003-12-23 2005-07-14 Alza Corporation Procedes et formes posologiques permettant d'augmenter la solubilite de compositions medicamenteuses en vue d'une administration controlee
WO2005065648A2 (fr) * 2003-12-29 2005-07-21 Alza Corporation, Inc., Nouvelles preparations de medicaments et formes posologiques de topiramate
CA2551815A1 (fr) * 2003-12-29 2005-07-21 Alza Corporation Compositions medicamenteuses et formes pharmaceutiques
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
WO2005072701A1 (fr) 2004-01-20 2005-08-11 Allergan, Inc. Compositions pour therapie localisee de l'oeil, de preference a base de triamcinolone acetonide et d'acide hyaluronique
TWI483944B (zh) 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
BRPI0510485A (pt) 2004-04-30 2007-11-13 Allergan Inc implantes inibidores de tirosina cinase intravìtreos biodegradáveis
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US7771742B2 (en) * 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US20050244472A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
US7993634B2 (en) * 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244461A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Controlled release drug delivery systems and methods for treatment of an eye
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US20050244500A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intravitreal implants in conjuction with photodynamic therapy to improve vision
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US20050244462A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
US20050244466A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Photodynamic therapy in conjunction with intraocular implants
US20050244471A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US20060185357A1 (en) * 2004-05-07 2006-08-24 Kovacevich Ian D Independently drawing and tensioning lines with bi-directional rotary device having two spools
US20050255406A1 (en) * 2004-05-11 2005-11-17 Shlomo Assa Marking on a thin film
DE102004023069A1 (de) 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US20060009425A1 (en) * 2004-05-28 2006-01-12 Leticia Delgado-Herrera Oral formulations of paricalcitol
EP1604666A1 (fr) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement de la bronchopneumopathie chronique obstructive
EP1604667A1 (fr) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement des impatiences des membres inférieurs
WO2005123039A1 (fr) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Formulations de prevention des abus
US7713550B2 (en) * 2004-06-15 2010-05-11 Andrx Corporation Controlled release sodium valproate formulation
US20050276849A1 (en) * 2004-06-15 2005-12-15 Nilobon Podhipleux Sustained release dosage forms
US20050276848A1 (en) * 2004-06-15 2005-12-15 Nilobon Podhipleux Sustained release neutralized divalproex sodium
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
WO2006007323A2 (fr) * 2004-06-28 2006-01-19 Alza Corporation Formes posologiques pour agents pharmaceutiques exempts d'acides a taux de dissolution et/ou de solubilite bas
WO2006007354A2 (fr) * 2004-06-28 2006-01-19 Alza Corporation Systeme d'administration par voie orale comprenant un complexe medicament/polymere
AU2005271700B2 (en) * 2004-07-12 2010-11-11 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
US20060128676A1 (en) * 2004-07-13 2006-06-15 Pharmacofore, Inc. Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
KR20070043894A (ko) * 2004-08-19 2007-04-25 알자 코포레이션 제어 방출형 나노입자 활성제 제제 제형 및 방법
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
WO2006043965A1 (fr) * 2004-10-14 2006-04-27 Allergan, Inc. Compositions ophtalmiques therapeutiques contenant des excipients sans danger pour la retine et leurs methodes
WO2006050471A2 (fr) * 2004-11-03 2006-05-11 Xenoport, Inc. Prodrogues d'acyloxyalkyl carbamate de l'acide 3-aminopropylsulfinique, et procedes de synthese et d'utilisation
WO2006050472A2 (fr) * 2004-11-03 2006-05-11 Xenoport, Inc. Prodrogues d'acyloxyalkyl carbamate, et leurs procedes de synthese et d'utilisation
AU2005301970B2 (en) * 2004-11-04 2011-06-02 Arbor Pharmaceuticals, Llc Gabapentin prodrug sustained release oral dosage forms
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
KR20090029856A (ko) * 2005-01-28 2009-03-23 유로-셀띠끄 소시에떼 아노님 알코올 저항성 제형
EP1695700A1 (fr) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Forme posologique contenant de l'oxycodone et de la naloxone
EP1702558A1 (fr) 2005-02-28 2006-09-20 Euro-Celtique S.A. Procédé et dispositif pour évaluer la fonction de l'activité intestinale
US7394479B2 (en) 2005-03-02 2008-07-01 Marken Corporation Pulsed laser printing
JP5114382B2 (ja) 2005-04-08 2013-01-09 アボット・ラボラトリーズ フェノフィブリン酸および／またはそれの塩を含む経口医薬製剤
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
US20060229261A1 (en) * 2005-04-12 2006-10-12 John Devane Acarbose methods and formulations for treating chronic constipation
ES2345784T3 (es) 2005-06-20 2010-10-01 Xenoport, Inc. Profarmacos de aciloxialquilcarbamato del acido tranexamico y uso de los mismos.
EP1896002A4 (fr) 2005-06-27 2009-11-25 Biovail Lab Int Srl Formulations a liberation modifiee d'un sel de bupropion
CN101291652A (zh) * 2005-06-29 2008-10-22 阿尔扎公司 对渗透剂型提供降低的干燥时间的半渗透性组合物
ES2296454B1 (es) * 2005-07-06 2009-05-05 Osmotica Corp. Sistema y metodo de perforacion laser.
TWI279234B (en) * 2005-07-12 2007-04-21 Anchen Pharmaceuticals Taiwan Method for controlling lag time of in-situ passageway formation in osmotic delivery system
WO2007019393A2 (fr) * 2005-08-04 2007-02-15 Alza Corporation Formes posologiques osmotiques comprenant des membranes semi-permeables formees de melanges polymeres presentant des caracteristiques ameliorees
WO2007027476A2 (fr) * 2005-08-26 2007-03-08 Xenoport, Inc. Traitement de l'ejaculation prematuree utilisant des prodrogues de gabapentine et de pregabaline
US20070191272A1 (en) * 2005-09-27 2007-08-16 Stemmer Willem P Proteinaceous pharmaceuticals and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
US20070190137A1 (en) * 2005-10-07 2007-08-16 Reyes Iran Osmotic dosage form with controlled release and fast release aspects
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
CA2841386A1 (fr) 2005-12-30 2007-07-12 Zensun (Shanghai) Science & Technology Limited Liberation etendue de neureguline destinee a ameliorer la fonction cardiaque
WO2007081736A1 (fr) * 2006-01-06 2007-07-19 Alza Corporation Forme de dosage osmotique avec libération contrôlée et aspects de libération rapide
US20090022798A1 (en) * 2007-07-20 2009-01-22 Abbott Gmbh & Co. Kg Formulations of nonopioid and confined opioid analgesics
US20100172989A1 (en) * 2006-01-21 2010-07-08 Abbott Laboratories Abuse resistant melt extruded formulation having reduced alcohol interaction
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
EP1813276A1 (fr) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Formes de dosage inviolables
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
WO2007106349A2 (fr) 2006-03-10 2007-09-20 Neurogen Corporation Pipérazinyl-oxoalkyl-tétrahydroisoquinoléines et analogues apparentés
BRPI0712819B8 (pt) 2006-05-26 2021-05-25 Pharmacofore Inc composto para liberação controlada de opióides fenólicos, processo para a preparação do referido composto e composição farmacêutica
EP2526932B1 (fr) 2006-06-19 2017-06-07 Alpharma Pharmaceuticals LLC Composition pharmaceutique
US20070298073A1 (en) * 2006-06-23 2007-12-27 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20080069871A1 (en) * 2006-07-21 2008-03-20 Vaughn Jason M Hydrophobic abuse deterrent delivery system
CN100396278C (zh) * 2006-07-24 2008-06-25 冯莉萍 药用微丸丸芯及制备方法
US20080045603A1 (en) * 2006-08-04 2008-02-21 John Devane Methods for treating at least one condition having MT1 receptor, 5HT2B receptor, and L-type calcium channel activity
WO2008033572A1 (fr) * 2006-09-15 2008-03-20 Xenoport, Inc. Promédicaments à base de carbamate d'acyloxyalkyle, procédés de synthèse et utilisation
EA201300152A1 (ru) 2006-11-27 2013-07-30 Х. Лундбекк А/С Гетероариламидные производные
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
WO2008073576A1 (fr) * 2006-12-08 2008-06-19 Alcon, Inc. Dispositif d'administration de médicaments
MX2009006080A (es) * 2006-12-08 2009-07-14 Xenoport Inc Uso de profarmacos de analogos de gaba para el tratamiento de enfermedades.
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
WO2008084698A1 (fr) 2006-12-28 2008-07-17 Astellas Pharma Inc. Composition pharmaceutique à libération entretenue de tacrolimus
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
US7911053B2 (en) * 2007-04-19 2011-03-22 Marvell World Trade Ltd. Semiconductor packaging with internal wiring bus
KR20100058541A (ko) * 2007-08-15 2010-06-03 아뮤닉스 인코포레이티드 생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법
WO2009027852A2 (fr) * 2007-08-28 2009-03-05 Agi Therapeutics, P.L.C. Procédés et compositions de traitement de troubles gastro-intestinaux
WO2009075782A1 (fr) 2007-12-06 2009-06-18 Durect Corporation Procédés utiles dans le traitement de la douleur, d'états rhumatismaux ou d'inflammations associées à un état chronique
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
PE20110422A1 (es) * 2008-07-07 2011-07-01 Euro Celtique Sa Composicion farmaceutica que comprende antagonistas opioides
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US20110046060A1 (en) 2009-08-24 2011-02-24 Amunix Operating, Inc., Coagulation factor IX compositions and methods of making and using same
DK3178835T3 (da) 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme
EP3045043B1 (fr) 2009-02-26 2020-04-29 Relmada Therapeutics, Inc. Compositions pharmaceutiques orales à libération prolongée de 3-hydroxy-n-méthylmorphinane et procédé d'utilisation
PT2405915T (pt) 2009-03-10 2019-01-29 Euro Celtique Sa Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
PE20121539A1 (es) 2009-06-08 2012-12-06 Amunix Operating Inc Polipeptidos de la hormona de crecimiento y metodos de preparacion
PT2440228T (pt) 2009-06-08 2018-12-24 Amunix Operating Inc Polipéptidos de regulação da glicose e métodos de preparação e utilização dos mesmos
WO2011028234A1 (fr) * 2009-09-04 2011-03-10 Xenoport, Inc. Utilisations de promédicaments acyloxyalkyl carbamates de l'acide tranexamique
NZ716349A (en) 2009-11-09 2017-07-28 Allergan Inc Compositions and methods for stimulating hair growth
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US20110184060A1 (en) * 2010-01-22 2011-07-28 Xenoport, Inc. Oral dosage forms having a high loading of a tranexamic acid prodrug
WO2011122524A1 (fr) 2010-03-29 2011-10-06 アステラス製薬株式会社 Composition pharmaceutique à libération contrôlée
CN103228142A (zh) 2010-09-28 2013-07-31 加利福尼亚大学董事会 治疗代谢综合征相关疾病的gaba激动剂和治疗或预防i型糖尿病的gaba组合
MY166034A (en) 2010-12-22 2018-05-21 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
US9233073B2 (en) 2010-12-23 2016-01-12 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
EP2755826B1 (fr) 2011-09-16 2019-05-01 Tri-Star Technologies Système et procédé de marquage laser de capsules
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
CN103202768B (zh) * 2012-01-11 2014-04-09 玄文明 一种药片盘式负压处理装置
BR112014020694A2 (pt) 2012-02-15 2018-05-08 Amunix Operating Inc. proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a
AU2013204636B2 (en) 2012-02-15 2016-04-14 Bioverativ Therapeutics Inc. Recombinant Factor VIII proteins
CA2868413C (fr) 2012-04-17 2021-07-20 Purdue Pharma L.P. Systemes et procedes de traitement d'une reponse pharmacodynamique indesirable induite par un opioide
CN102699539B (zh) * 2012-06-14 2014-07-30 天津工业自动化仪表研究所有限公司 一种全功能渗透泵控释片激光打孔机
NZ715111A (en) 2012-07-16 2016-12-23 Rhodes Technologies Process for improved opioid synthesis
BR112015000944A2 (pt) 2012-07-16 2019-10-15 Rhodes Tech processo para síntese melhorada de opioide
US10149390B2 (en) * 2012-08-27 2018-12-04 Mycronic AB Maskless writing of a workpiece using a plurality of exposures having different focal planes using multiple DMDs
ES2851175T3 (es) 2013-02-05 2021-09-03 Purdue Pharma Lp Formulaciones farmacéuticas resistentes a manipulación
WO2014127243A1 (fr) 2013-02-15 2014-08-21 Allergan, Inc. Implant à administration de médicament prolongée
WO2014144975A1 (fr) 2013-03-15 2014-09-18 Durect Corporation Compositions ayant un agent de modification rhéologique pour réduire une variabilité de dissolution
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9855245B2 (en) 2013-04-30 2018-01-02 Abbvie Inc. Methods for improving lipid profiles using atrasentan
SG11201509738RA (en) 2013-05-31 2015-12-30 Takeda Pharmaceuticals Usa Inc Methods of treatment and compositions with xanthine oxidase inhibitors
WO2014197744A1 (fr) 2013-06-05 2014-12-11 Synchroneuron, Inc. Formulations d'acamprosate, procédés d'utilisation de celles-ci, et combinaisons comprenant celles-ci
US20160120861A1 (en) 2013-06-28 2016-05-05 Purdue Pharma L.P. Compositions and Methods for Treating an Arrhythmia with an Opioid Antagonist
EP3024461B1 (fr) 2013-07-23 2020-05-13 Euro-Celtique S.A. Combinaison d'oxycodone et de la naloxone pour utilisation dans le traitement de la douleur chez des patients souffrant de douleurs et d'une maladie résultant de dysbioses intestinales et/ou augmentant le risque de la la translocation bacterienne
AU2014298257B2 (en) 2013-08-02 2016-11-10 Macfarlan Smith Limited Process for the preparation of oxymorphone
TWI667255B (zh) 2013-08-14 2019-08-01 美商生物化學醫療公司 因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
ES2672795T3 (es) 2014-01-15 2018-06-18 Rhodes Technologies Proceso para la síntesis mejorada de oximorfona
AU2015207733A1 (en) 2014-01-15 2016-07-14 Rhodes Technologies Process for improved oxycodone synthesis
US9062063B1 (en) 2014-03-21 2015-06-23 Johnson Matthey Public Limited Company Forms of oxymorphone hydrochloride
CN105583531B (zh) * 2014-10-23 2017-08-22 大族激光科技产业集团股份有限公司 一种高速精准药片激光打孔机
JP2016097438A (ja) * 2014-11-26 2016-05-30 元成機械股▲ふん▼有限公司 レーザー穴あけシステム
US9918979B2 (en) 2015-01-29 2018-03-20 Johnson Matthey Public Limited Company Process of preparing low ABUK oxymorphone hydrochloride
WO2016132218A1 (fr) 2015-02-20 2016-08-25 Osmotica Kereskedelmi Es Szolgaltato Kft Méthode d'administration de r-baclofène dans une forme pharmaceutique à libération prolongée
TWI741992B (zh) 2015-08-03 2021-10-11 美商百歐維拉提夫治療公司 因子ｉｘ融合蛋白以及其製備及使用方法
GB2556817B (en) 2015-10-01 2019-11-06 Elysium Therapeutics Inc Polysubunit opioid prodrugs resistant to overdose and abuse
US10335406B2 (en) 2015-10-01 2019-07-02 Elysium Therapeutics, Inc. Opioid compositions resistant to overdose and abuse
US20170296471A1 (en) * 2016-04-13 2017-10-19 Scantech Laser Pvt. Ltd. Unique high speed tablet drilling laser system
WO2017222575A1 (fr) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Procédé de préparation de formulations orales dissuasives d'abus plus stables
WO2018170465A1 (fr) 2017-03-17 2018-09-20 Elysium Therapeutics, Inc. Promédicaments d'opioïdes à sous-unités multiples résistants aux surdoses et aux abus
CN109434297A (zh) * 2017-06-07 2019-03-08 合肥智慧龙图腾知识产权股份有限公司 一种微调型激光切割装置
JP2021513987A (ja) 2018-02-16 2021-06-03 エスペリオン・セラピューティクス・インコーポレイテッドＥｓｐｅｒｉｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． ベンペド酸の持続放出製剤
MX2020012397A (es) 2018-05-18 2021-04-12 Bioverativ Therapeutics Inc Metodos de tratamiento de la hemofilia a.
BR112020026644A2 (pt) 2018-07-24 2021-03-23 Bayer Aktiengesellschaft Forma de dosagem farmacêutica que pode ser administrada oralmente e tem liberação modificada
WO2020020790A1 (fr) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Formes galéniques pharmaceutiques à libération modifiée à administrer par voie orale
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
US10583668B2 (en) 2018-08-07 2020-03-10 Markem-Imaje Corporation Symbol grouping and striping for wide field matrix laser marking
CN110181183A (zh) * 2019-07-08 2019-08-30 深圳市大鹏激光科技有限公司 一种光纤激光切割机
JPWO2021029020A1 (fr) 2019-08-13 2021-02-18
BR112022025185B1 (pt) 2020-06-10 2023-10-24 Auspex Pharmaceuticals, Inc Formas de dosagem osmóticas compreendendo deutetrabenazina e métodos de uso das mesmas
WO2023240186A1 (fr) 2022-06-08 2023-12-14 Auspex Pharmaceuticals, Inc. Formes posologiques osmotiques comprenant de la deutétrabénazine et leurs procédés d'utilisation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216107A (en) * 1879-06-03 Improvement in pill-machines
US3404254A (en) * 1965-02-26 1968-10-01 Minnesota Mining & Mfg Method and apparatus for engraving a generally cross-sectionally circular shaped body by a corpuscular beam
US3562377A (en) * 1966-06-20 1971-02-09 James B Zetzsche Jr Method of forming irrigation pipe
US3620759A (en) * 1969-04-01 1971-11-16 Parke Davis & Co Food capsule
BE794951A (fr) * 1972-02-03 1973-05-29 Parke Davis & Co Conditionnement soluble dans l'eau
US3808394A (en) * 1972-03-31 1974-04-30 Anjac Plastics Creating holes in flexible members
AU466503B2 (en) * 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
DE2350933C3 (de) * 1973-10-10 1981-10-29 Winkler & Dünnebier, Maschinenfabrik und Eisengießerei GmbH & Co KG, 5450 Neuwied Vorrichtung zum Formbrennschneiden einer bewegten Materialbahn mittels eines Laserstrahles

Also Published As

Publication number Publication date
SE420804B (sv) 1981-11-02
SE7512838L (sv) 1976-05-19
AU498851B2 (en) 1979-03-29
JPS5176416A (en) 1976-07-02
CH604696A5 (fr) 1978-09-15
DE2551241C2 (de) 1985-01-03
FR2290888A1 (fr) 1976-06-11
AU8638875A (en) 1977-05-12
GB1478759A (en) 1977-07-06
DE2551241A1 (de) 1976-05-20
US4088864A (en) 1978-05-09
CA1033013A (fr) 1978-06-13
IT1050948B (it) 1981-03-20
JPS609814B2 (ja) 1985-03-13

Similar Documents

Publication Publication Date Title
FR2290888B1 (fr)
FI750706A (fr)
FR2294642B1 (fr)
FR2289118B1 (fr)
FR2264271B1 (fr)
FR2284427B1 (fr)
FR2267303B1 (fr)
JPS50111696A (fr)
AU495844B2 (fr)
JPS50115499U (fr)
JPS50101276U (fr)
JPS50108986U (fr)
JPS50109660A (fr)
JPS50111478U (fr)
BG19713A1 (fr)
CH571742A5 (fr)
CH1126075A4 (fr)
BG20461A1 (fr)
AU481441A (fr)
BE833996A (fr)
CH116575A4 (fr)
CH1174575A4 (fr)
BG19663A1 (fr)
BG20237A1 (fr)
BG19946A1 (fr)